about
Age and the metabolic syndrome affect salivary cortisol rhythm: data from a community sample.Body Composition is Different After Surgical or Pharmacological Remission of Cushing's Syndrome: A Prospective DXA Study.Predicting late recurrence in surgically treated patients with Cushing's disease.Second-line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome.Diagnostic accuracy of increased urinary cortisol/cortisone ratio to differentiate ACTH-dependent Cushing's syndrome.A venous thromboembolism risk assessment model for patients with Cushing's syndrome.Screening Tests for Cushing's Syndrome: Urinary Free Cortisol Role Measured by LC-MS/MS.The role of an acute pasireotide suppression test in predicting response to treatment in patients with Cushing's disease: findings from a pilot study.Early recognition of aggressive pituitary adenomas: a single-centre experience.Cardiovascular autonomic dysfunction in patients with idiopathic diabetes insipidus.Decrease in salivary cortisol levels after glucocorticoid dose reduction in patients with adrenal insufficiency: A prospective proof-of-concept study.Daily salivary cortisol and cortisone rhythm in patients with adrenal incidentaloma.Medical Treatment for Acromegaly does not Increase the Risk of Central Adrenal Insufficiency: A Long-Term Follow-Up Study.Diagnosis and complications of Cushing's disease: gender-related differences.Perioperative thromboprophylaxis in Cushing's disease: What we did and what we are doing?Diabetes Mellitus Secondary to Cushing's Disease.The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome.Thrombin generation in Cushing's Syndrome: do the conventional clotting indices tell the whole truth?Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?An analysis of different therapeutic options in patients with Cushing's syndrome due to bilateral macronodular adrenal hyperplasia: a single-centre experienceEffects of pasireotide treatment on coagulative profile: a prospective study in patients with Cushing's diseaseMetyrapone treatment in Cushing's syndrome: a real-life studyImproved salivary cortisol rhythm with dual-release hydrocortisonePitfalls in urinary sodium excretionRapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumabThe pathogenic role of the GIP/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetesPerioperative multidisciplinary management of endoscopic transsphenoidal surgery for sellar lesions: practical suggestions from the Padova modelActivation profiles of monocyte-macrophages and HDL function in healthy women in relation to menstrual cycle and in polycystic ovary syndrome patientsIs pasireotide-induced diabetes mellitus predictable? A pilot study on the effect of a single dose of pasireotide on glucose homeostasis
P50
Q30981349-E700AF70-867F-4B77-9C85-97F38E4EEBB5Q38674405-60A38208-43DB-4ED1-A457-12F02E44F8CCQ39493301-B2252F3F-4553-4A3D-83D7-585E410BF469Q39728429-EF76D18D-DFE7-4317-B76F-D7670CDAF8DFQ40169381-9E86C94A-5051-4CA0-8675-7B602436CCEFQ40795123-62534EEB-F8D4-44E8-8208-6228752B5F26Q41482557-7C61B62D-5FD7-411B-B684-878EB4EB0597Q41698329-ED5993D5-9490-46B5-800B-822E0FC3259DQ47573398-2701CD57-FA0E-4189-80D9-931C4D3FFF50Q47729136-48B19944-ACA8-4214-B393-EAE1F1A0B16BQ48251457-AC5FB647-D96D-46B5-B5C7-2CDED566611EQ48278106-AFF65AB2-8BF5-4F61-959B-0D609A1102B1Q48703996-CBA86FB9-6058-4BEE-81F4-E0FEEC586A85Q51221036-0476DF5B-AFAB-4DDF-9755-2F0DAF3F0ABEQ53439990-C687390F-7509-417D-9B2E-A9D368548CFFQ55425212-8A4D928F-9CB0-4A3A-8A38-A7578154D4F2Q64986758-2A70B140-A703-4D1F-86E2-7796E5AE1CFBQ86113807-7CE3EE0C-0DBA-4C2C-9ECF-24A5583D2864Q86299876-BD498D3B-FC36-4297-AC42-FE7589ACC78FQ86848341-4E2BD9C1-B99B-4EC0-99D1-960A82513701Q89450813-FB6DE347-07F7-49FF-A086-1758DCD2B14AQ90266248-9BFD8B2E-B393-4461-8AFF-D4A406B2D82BQ90521166-11AA7889-16BC-4A12-A456-326775F4B142Q90831813-1052B982-745B-49C7-B7FB-11D88A05630DQ91189209-3AAC646F-5637-4A02-936D-2229EFF66676Q92613514-78293BE3-D189-4A60-AA7E-81E372AD16B3Q92949986-ECD24A3D-5995-4B3C-A3A6-0077BBD8C1D8Q93144871-2B51BDD7-C65E-4F82-875C-D6A2BC4C65C2Q96307340-396FFF0E-FBBC-4E9B-A47C-110B8802D6AE
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Mattia Barbot
@en
Mattia Barbot
@nl
type
label
Mattia Barbot
@en
Mattia Barbot
@nl
prefLabel
Mattia Barbot
@en
Mattia Barbot
@nl
P31
P496
0000-0002-1081-5727